“Swiss Consensus Statement: Recommendations for Optimising Re-Treatment With MabThera® (rituximab) in Rheumatoid Arthritis”. Swiss Medical Weekly 140, no. 2728 (July 5, 2010): w13073. Accessed January 11, 2026. https://www.smw.ch/index.php/smw/article/view/1150.